Learn about the emergence of psychedelic drugs, their importance & how a Laboratory Information Management System (LIMS) can assure their quality testing.
Regular cannabis consumers tend to have a lower resting heart rate than those who don’t use the drug, according to a new study.
Despite this retraction the original study’s main conclusion, that cannabis legalization doesn’t seem to encourage adolescent use of the drug, remains intact.
To learn more about the event and what attendees can expect, Analytical Cannabis caught up with one its speakers, Dr Callie Seaman, an honorary researcher at Sheffield Hallam University and executive director and scientific lead at Medcan Support.
A non-invasive brain stimulation technique may help to reduce problematic cannabis use in people with schizophrenia, a new study led by the Centre for Addiction and Mental Health has found.
Cannabis testing labs in Washington will soon be required to test for pesticides.
In a new Analytical Cannabis webinar held on March 8, Eric Janusson, lead chemist at the Vancouver-based Delic Labs, will present new methods being developed by Delic to produce accurate results for psilocybin quantitation. Here's what he had to say ahead of that webinar.
After giving the drugs to participants and reviewing their experiences, the researchers concluded that both doses of LSD and the higher dose of psilocybin produced comparable psychedelic effects.